Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Barclays Reaffirms Their Buy Rating on Centene (CNC)

Tipranks - Tipranks - Fri Apr 10, 3:48AM CDT

Barclays analyst Andrew Mok CFA maintained a Buy rating on Centene today and set a price target of $54.00.

Easter Sale - 70% Off TipRanks

Mok CFA covers the Healthcare sector, focusing on stocks such as Brookdale Senior Living, Encompass Health, and Universal Health. According to TipRanks, Mok CFA has an average return of -2.6% and a 45.28% success rate on recommended stocks.

In addition to Barclays, Centene also received a Buy from Bernstein’s Lance Wilkes in a report issued on April 6. However, today, TipRanks – DeepSeek reiterated a Hold rating on Centene (NYSE: CNC).

See today’s best-performing stocks on TipRanks >>

Based on Centene’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $49.73 billion and a GAAP net loss of $1.1 billion. In comparison, last year the company earned a revenue of $40.81 billion and had a net profit of $283 million

Read More on CNC:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).